These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10802809)

  • 1. Transderm-induced psychosis in Parkinson's disease.
    Quinn N
    Neurology; 2000 May; 54(9):1877. PubMed ID: 10802809
    [No Abstract]   [Full Text] [Related]  

  • 2. Transderm-induced psychosis in Parkinson's disease.
    Minagar A; Shulman LM; Weiner WJ
    Neurology; 1999 Jul; 53(2):433-4. PubMed ID: 10430448
    [No Abstract]   [Full Text] [Related]  

  • 3. Toxic psychosis from transdermal scopolamine in a child.
    Sennhauser FH; Schwarz HP
    Lancet; 1986 Nov; 2(8514):1033. PubMed ID: 2877187
    [No Abstract]   [Full Text] [Related]  

  • 4. Transdermal scopolamine as a cause of transient psychosis in two elderly patients.
    Mego DM; Omori JM; Hanley JF
    South Med J; 1988 Mar; 81(3):394-5. PubMed ID: 3347867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Scopolamine plaster caused hallucination. Toxic psychosis in a 10-year-old boy caused by an agent against motion sickness].
    Björk M; Wettergren B
    Lakartidningen; 1995 Feb; 92(7):638. PubMed ID: 7861858
    [No Abstract]   [Full Text] [Related]  

  • 6. [A draftee got a CNS disorder after treatment with scopolamine plaster].
    Olevik P
    Lakartidningen; 1987 Apr; 84(17):1463. PubMed ID: 3586788
    [No Abstract]   [Full Text] [Related]  

  • 7. [An unusual case of psychosis caused by long-term administration of a scopolamine membrane patch. Paranoid hallucinogenic and delusional symptoms].
    Rubner O; Kummerhoff PW; Haase H
    Nervenarzt; 1997 Jan; 68(1):77-9. PubMed ID: 9132625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal scopolamine and toxic psychosis.
    Rodysill KJ; Warren JB
    Ann Intern Med; 1983 Apr; 98(4):561. PubMed ID: 6838088
    [No Abstract]   [Full Text] [Related]  

  • 9. Transdermal scopolamine intoxication in a child.
    Klein BL; Ashenburg CA; Reed MD
    Pediatr Emerg Care; 1985 Dec; 1(4):208-9. PubMed ID: 3842169
    [No Abstract]   [Full Text] [Related]  

  • 10. Ocular scopolamine-induced psychosis.
    Birkhimer LJ; Jacobson PA; Olson J; Goyette DM
    J Fam Pract; 1984 Mar; 18(3):464, 466, 469. PubMed ID: 6699585
    [No Abstract]   [Full Text] [Related]  

  • 11. Transdermal scopolamine-induced psychosis.
    Ziskind AA
    Postgrad Med; 1988 Sep; 84(3):73-6. PubMed ID: 2901077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visual side-effects from transdermal scopolamine (hyoscine).
    Firth AY; Walker K
    Dev Med Child Neurol; 2006 Feb; 48(2):137-8. PubMed ID: 16417670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scopolamine: new preparations. Reference treatment for death rattle.
    Prescrire Int; 2001 Aug; 10(54):99-101. PubMed ID: 11718188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of motion sickness remedies in severe sea conditions.
    Gahlinger PM
    Wilderness Environ Med; 2000; 11(2):136-7. PubMed ID: 10921365
    [No Abstract]   [Full Text] [Related]  

  • 15. Mental confusion associated with scopolamine patch in elderly with mild cognitive impairment (MCI).
    Seo SW; Suh MK; Chin J; Na DL
    Arch Gerontol Geriatr; 2009; 49(2):204-207. PubMed ID: 18834638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Red as a beet.
    Blumenthal HJ
    J Okla State Med Assoc; 2007 Apr; 100(4):113. PubMed ID: 17476994
    [No Abstract]   [Full Text] [Related]  

  • 17. A case of hyoscine-related oesophagitis.
    Philcox S; Keegan A
    Med J Aust; 2007 Jun; 186(12):650-1. PubMed ID: 17576184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scopolamine psychosis revisited.
    Cairncross JG
    Ann Neurol; 1983 May; 13(5):582. PubMed ID: 6870212
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacotoxic psychosis after memantine in Parkinson's disease.
    Riederer P; Lange KW; Kornhuber J; Danielczyk W
    Lancet; 1991 Oct; 338(8773):1022-3. PubMed ID: 1681331
    [No Abstract]   [Full Text] [Related]  

  • 20. Pulsed intravenous administration of scopolamine produces rapid antidepressant effects and modest side effects.
    Furey ML; Zarate CA
    J Clin Psychiatry; 2013 Aug; 74(8):850-1. PubMed ID: 24021505
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.